Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxiredoxin-2 is a thiol-specific peroxidase enzyme highly expressed in human erythrocytes (red blood cells) and encoded by the PRDX2 gene. It catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively, thereby protecting cells against oxidative damage. Structurally, peroxiredoxin-2 can exist as monomers, dimers, and higher oligomers, cycling between redox states during its catalytic process. The enzyme employs a thioredoxin-dependent mechanism for reduction and is susceptible to overoxidation, which can convert it into a molecular chaperone. Peroxiredoxin-2 is a crucial antioxidant enzyme involved in cell signaling, antiviral defense, protection from oxidative stress, and can modulate cell proliferation. Its dysregulation has been implicated in cancer, inflammatory conditions, cardiovascular disease, immune responses, and diseases of oxidative injury.
Inhibition or modulation of peroxidase activity (for preclinical compounds); Disruption of redox cycling; Augmentation or suppression of antioxidant response
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxiredoxin-2 (PRDX2).